Description: Hemcheck Sweden AB (publ) operates as a medical technology company in Sweden. The company develops and commercializes Helge, which detects hemolysis in blood samples at the point of care. It serves emergency departments in the European Union and the United States. The company was founded in 2010 and is based in Karlstad, Sweden.
Home Page: www.hemcheck.com
Karlstads universitet
Karlstad,
651 88
Sweden
Phone:
46 76 108 81 91
Officers
| Name | Title |
|---|---|
| Mr. Joen Averstad | Chief Exec. Officer |
| Mr. Robert Thoren | Chief Financial Officer |
| Mr. David Melin | Chief Technology Officer |
| Mr. Peter Andersson | Sales & Marketing Mang. and Deputy CEO |
| Mr. Henrik Duhalde | Clinical Specialist |
Exchange: ST
Country: SE
Currency: Swedish krone (kr)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.2355 |
| Price-to-Sales TTM: | 1.6517 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 6 |